Dual time-point 18F-FDG PET/CT to assess response to radiofrequency ablation of lung metastases

被引:5
|
作者
Lafuente, S. [1 ]
Fuster, D. [1 ]
Arguis, P. [2 ]
Granados, U. [1 ]
Perlaza, P. [1 ]
Paredes, P. [1 ]
Vollmer, I. [2 ]
Sanchez, M. [2 ]
Lomena, F. [1 ]
机构
[1] Hosp Clin Barcelona, Dept Nucl Med, Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Radiol, Barcelona, Spain
关键词
PET/CT; Delayed images; Radiofrequency; Lung metastases; Gastrointestinal cancer; FOLLOW-UP; PERCUTANEOUS RADIOFREQUENCY; PULMONARY NODULES; FDG-PET/CT; CT; TUMORS;
D O I
10.1016/j.remn.2015.12.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim: To establish the usefulness of dual time-point PET/CT imaging in determining the response to radiofrequency ablation (RFA) of solitary lung metastases from gastrointestinal cancer. Materials and methods: This prospective study included 18 cases (3 female, 15 male, mean age 71 +/- 15 yrs) with solitary lung metastases from malignant digestive tract tumors candidates for RFA. PET/CT images 1 h after injection of 4.07 MBq/kg of F-18-FDG (standard images) were performed at baseline, 1 month, and 3 months after RFA. PET/CT images 2 h after injection centered in the thorax at 1 month after RFA were also performed (delayed images). A retention index (RI) of dual time-point images was calculated as follows: RI = (SUVmax delayed image - SUVmax standard image/SUVmax standard image) *100. Pathological confirmation of residual tumor by histology of the treated lesion was considered as local recurrence. A negative imaging follow-up was considered as complete response. Results: Local recurrence was found in 6/18 lesions, and complete response in the remaining 12. The mean percentage change in SUVmax at 1 month and at 3 months showed a sensitivity and specificity for PET/CT of 50% and 33%, and 67% and 92%, respectively. The RI at 1 month after RFA showed a sensitivity and specificity of 83% and 92%, respectively. Conclusions: Dual time point PET/CT can predict the outcome at one month after RFA in lung metastases from digestive tract cancers. The RI can be used to indicate the need for further procedures to rule out persistent tumor due to incomplete RFA. (C) 2015 Elsevier Espana, S.L.U. y SEMNIM. All rights reserved.
引用
收藏
页码:226 / 231
页数:6
相关论文
共 50 条
  • [1] Evaluation of liver metastases after radiofrequency ablation:: Utility of 18F-FDG PET and PET/CT
    Barker, DW
    Zagoria, RJ
    Morton, KA
    Kavanagh, PV
    Shen, P
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (04) : 1096 - 1102
  • [2] 18F-FDG PET/CT evaluation of radiofrequency ablation of lung tumours.
    Coronado, M.
    Rodado, S.
    Escabias, C.
    Hernandez, A. C.
    Marin, M. D.
    Mendez, D.
    Coya, J.
    Oliver, J. M.
    Martin, L. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S425 - S425
  • [3] Dual Time-Point 18F-FDG PET/CT in Spinal Sarcoidosis A Single Institution Case Series
    Ordonez-Rubiano, Edgar G.
    Solano-Noguera, Diego F.
    Row, William
    Weinberg, Jeffrey
    Tatsui, Claudio E.
    Johnson, Jason M.
    Gule-Monroe, Maria K.
    SPINE, 2019, 44 (21) : E1248 - E1255
  • [4] Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study
    Bonichon, Francoise
    Palussiere, Jean
    Godbert, Yann
    Pulido, Marina
    Descat, Edouard
    Devillers, Anne
    Meunier, Catherine
    Leboulleux, Sophie
    de Baere, Thierry
    Galy-Lacour, Claire
    Lagoarde-Segot, Laurent
    Cazeau, Anne-Laure
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (12) : 1817 - 1827
  • [5] Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study
    Françoise Bonichon
    Jean Palussière
    Yann Godbert
    Marina Pulido
    Edouard Descat
    Anne Devillers
    Catherine Meunier
    Sophie Leboulleux
    Thierry de Baère
    Claire Galy-Lacour
    Laurent Lagoarde-Segot
    Anne-Laure Cazeau
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 1817 - 1827
  • [6] 18F-FDG PET/CT in lung metastases treated by radiofrequency ablation: A multicenter prospective study(NCT 003382252).
    Pulido, Marina
    Palussiere, Jean
    Devillers, A.
    Meunier, C.
    Leboulleux, Sophie
    de Baere, T.
    Galy-Lacour, C.
    Lagoarde-Segot, Laurent
    Pulido, Marina
    Cazeau, Al
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [7] 18F-FDG PET/CT visualisation of tumor seeding after percutaneous radiofrequency ablation of metastases
    Zanotti-Fregonara, Paolo
    Hindie, Elif
    Albertini, Anne-Flore
    Ech-Charraq, Ikram
    Weinmann, Pierre
    Devaux, Jean-Yves
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (02) : 305 - 305
  • [8] 18F-FDG PET/CT visualisation of tumor seeding after percutaneous radiofrequency ablation of metastases
    Paolo Zanotti-Fregonara
    Elif Hindié
    Anne-Flore Albertini
    Ikram Ech-Charraq
    Pierre Weinmann
    Jean-Yves Devaux
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 305 - 305
  • [9] 18F-FDG PET/CT in Evaluation of Radiofrequency Ablation of Liver Metastasis
    Thulkar, Sanjay
    Chawla, Madhavi
    Sharma, Punit
    Malhotra, Arun
    Kumar, Rakesh
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (05) : 498 - 501
  • [10] 18F-FDG PET/CT of Lung Adenocarcinoma With Ovarian Metastases
    Garcia-Talavera, Paloma
    Colinas, Daniel
    Tamayo, Pilar
    Fra, Joaquin
    Montes, Arnold
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (05) : 397 - 398